$CL

Colgate-Palmolive: Base Business EPS Increases 8% As Gross Margin Expands 140 Basis Points

Colgate-Palmolive reported Q2 2026 Base Business diluted EPS up 8% to $0.99 from $0.92, driven by 140 bps gross-margin expansion to 61.5% and higher organic sales. Reported diluted EPS fell 5% to $0.86 due to $129m pretax charges tied to its Strategic Growth and Productivity Program. Net sales rose 4.9% to $5.36b. Full-year organic outlook 1% to 4%; Base Business EPS expected mid-single-digit growth.

Original reporting
Published Aug 3, 2026, 3:43 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 8:28 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Colgate-Palmolive: Base Business EPS Increases 8% As Gross Margin Expands 140 Basis Points — source image
Decision brief

The 30-second read

$CLBullishMed
01

Why it matters

Traders can reframe the quarter around Base Business EPS growth, gross margin expansion, and an updated Base Business EPS growth outlook, while monitoring whether elevated advertising sustains the margin trajectory.

02

Market read

A margin-led improvement and a guidance tweak for Base Business EPS are likely to be the primary drivers for positioning, despite GAAP EPS decline from restructuring costs.

03

What to watch

Advertising spend rose about 15% to $777 million and management plans elevated investment in H2, which could pressure margins if gross margin does not hold as expected.

Relevance 7/10Novelty 7/10Timing: pre-market today (results and outlook update reported for Q2 2026)

Background

The article summarizes Colgate-Palmolive’s Q2 2026 results, emphasizing Base Business metrics versus GAAP and detailing margin, sales, and restructuring-related adjustments.

Company-level read

Ticker impact

$CLBullishMedium confidence
Context

Colgate reported Base Business EPS up 8% to $0.99, with gross margin up 140 bps to 61.5% and raised Base Business EPS growth outlook to mid-single digits.

Expected impact

Near-term bias higher as traders focus on Base Business EPS and margin expansion, but GAAP EPS decline may cap upside.

Evidence & confidence

The article provides multiple directionally positive operating metrics (Base EPS, gross margin, Base operating profit) plus a specific outlook change, which typically drives earnings-multiple repricing. However, the GAAP EPS decline and restructuring charges introduce some uncertainty about the quality/timing of earnings power.

Market effects

Signals resilience in consumer staples personal care and pet nutrition demand, with margin support from pricing and brand investment.

North America organic volume weakness contrasts with Latin America and Asia Pacific growth, suggesting regional dispersion in consumer spending.

Improved gross margin and raised EPS growth guidance can influence sentiment toward large-cap packaged goods peers with similar pricing and advertising models.

Counterpoint

GAAP EPS fell 5% and the Strategic Growth and Productivity Program generated $129 million pretax adjustments, so the earnings quality may be partly transitional.

Key entities

  • Colgate-Palmolive

    Reported Q2 2026 Base Business EPS up 8% to $0.99, gross margin up 140 bps to 61.5%, and raised Base Business EPS growth outlook to mid-single digits.

Related articles

$CLMed

Colgate-Palmolive Reaffirms Sales Forecast On Weak Demand

Colgate-Palmolive reaffirmed its annual net sales forecast despite a quarterly rise, citing weak North America demand. In the quarter ended June 30, net sales rose 4.9% to $5.36 billion and adjusted EPS was 99 cents. North America organic sales fell 3%, with volumes down 3.9%. The company expects 2026 adjusted earnings growth in mid-single digits and warned tariffs could offset refunds.

$CLMed

Colgate-Palmolive Q2 Earnings Call Highlights

Colgate-Palmolive (NYSE:CL) CFO Stan Sutula said Q2 material costs were slightly below expectations due to higher raw-material costs offset by tariff refunds, with no meaningful additional refunds expected. Management now expects full-year gross margin roughly flat, and warned second-half raw-material and tariff costs will be higher. It plans elevated ad spending and North America share recovery; Hill’s organic sales rose 4% excluding discontinued private-label.

$CLHighAI 9/10

Colgate-Palmolive Q2 2026 slides: strong results fuel raised guidance

Colgate-Palmolive (NYSE:CL) reported Q2 2026 results on July 31. Net sales rose 4.9% to $5.36B and organic sales grew 2.4%. Base EPS increased 8% and free cash flow rose 18% YoY to $1.5B YTD. The company raised 2026 guidance, including flat gross margin outlook and higher EPS growth, and projected $350M to $550M pre-tax charges for its 2030 program.

$CLMed

Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down

Colgate-Palmolive reported Q2 net earnings of $693 million, down from $743 million a year earlier, with EPS falling to $0.86 from $0.91. Net sales rose to $5.361 billion. The company confirmed FY2026 outlook and raised Base Business EPS growth to mid-single-digit from low- to mid-single-digit, and expects gross margin roughly flat. Shares were down about 2.78% premarket.

$CLMed

Colgate-Palmolive reaffirms annual sales forecast on weak North America demand

Amazon shares rally as cloud growth surges and spending outlook climbs July 31 (Reuters) - Colgate-Palmolive on Friday reaffirmed its annual sales forecast even after posting a quarterly rise as the toothpaste maker continues to grapple with muted demand in North America, sending its shares down 2.5%. Higher food and fuel prices tied to the Middle East conflict have hit lower-income shoppers hard, making it harder for U.S.